A tool to facilitate clinical biomarker studies - a tissue dictionary based on the Human Protein Atlas

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Kampf, Caroline ^a   Bergman, Julia ^a   Oksvold, Per ^b   Asplund, Anna ^a   Navani, Sanjay ^c   Wiking, Mikaela ^b   Lundberg, Emma ^b   Uhlén, Mathias ^b   Ponten, Fredrik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c Lab Surgpath   (India)

Author keywords

Antibody based proteomics; cancer biomarkers; histology, pathology; immunohistochemistry; protein expression; tissue and cell dictionary

Indexed keywords

ARTICLE; BOOK; CANCER CELL; CANCER TISSUE; CYTOLOGY; HISTOLOGY; MEDICAL EDUCATION; MICROSCOPY; PATHOLOGY;

BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY; PROTEOME;

EID: 84866045885     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-103     Document Type: Article

References (17)

1. Uhlen M, Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005, 4:384-393. 10.1074/mcp.R500009-MCP200, 15695805.
2. Kampf C, Olsson I, Ryberg U, Sjostedt E, Ponten F. Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas. J Vis Exp 2012, (63):e3620. DOI: 10.3791/3620.
3. Barbe L, Lundberg E, Oksvold P, Stenius A, Lewin E, Bjorling E, Asplund A, Ponten F, Brismar H, Uhlen M, Andersson-Svahn H. Toward a confocal subcellular atlas of the human proteome. Mol Cell Proteomics 2008, 7:499-508.
4. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergström K, Brumer H, Cerjan D, Ekström M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Björklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4:1920-1932. 10.1074/mcp.M500279-MCP200, 16127175.
5. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Björling L, Ponten F. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250. 10.1038/nbt1210-1248, 21139605.
6. Bjorling E, Lindskog C, Oksvold P, Linne J, Kampf C, Hober S, Uhlen M, Ponten F. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics 2007, 7:825-44.
7. Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 2010, 10:605-617. 10.1038/nrc2902, 20720569.
8. Ponten F, Gry M, Fagerberg L, Lundberg E, Asplund A, Berglund L, Oksvold P, Bjorling E, Hober S, Kampf C, Navani S, Nilsson P, Ottosson J, Persson A, Wernérus H, Wester K, Uhlén M. A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol 2009, 5:337. 2824494, 20029370.
9. Magnusson K, De Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CA, Navani S, Uhlén M, O'Connor DP, Jirström K, Pontén F. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol 2011, 35:937-948. 10.1097/PAS.0b013e31821c3dae, 21677534.
10. Jogi A, Brennan DJ, Ryden L, Magnusson K, Ferno M, Stal O, Borgquist S, Uhlen M, Landberg G, Pahlman S, Pontén F, Jirström K. Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol 2009, 22:1564-1574. 10.1038/modpathol.2009.124, 19734850.
11. Hjelm B, Brennan DJ, Zendehrokh N, Eberhard J, Nodin B, Gaber A, Ponten F, Johannesson H, Smaragdi K, Frantz C, Hober S, Johnson LB, Påhlman S, Jirström K, Uhlen M. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. Proteomics Clin Appl 2011, 5:624-635. 10.1002/prca.201100020, 21956899.
12. Jonsson L, Bergman J, Nodin B, Manjer J, Ponten F, Uhlen M, Jirstrom K. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study. J Transl Med 2011, 9:114. 10.1186/1479-5876-9-114, 3156749, 21777469.
13. Ehlen A, Brennan DJ, Nodin B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J, Brandstedt J, Uhlen M, Pontén F, Jirström K. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med 2010, 8:78. 10.1186/1479-5876-8-78, 2936876, 20727170.
14. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirstrom K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 2011, 121:784-799. 10.1172/JCI43757, 3026724, 21266779.
15. Lindskog C, Asplund A, Engkvist M, Uhlen M, Korsgren O, Ponten F. Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets. Discov Med 2010, 9:565-578.
16. Lindskog C, Korsgren O, Ponten F, Eriksson JW, Johansson L, Danielsson A. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. J Proteomics 2012, 75:2611-2620. 10.1016/j.jprot.2012.03.008, 22465717.
17. Ponten F, Schwenk JM, Asplund A, Edqvist PH. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med 2011, 270:428-446. 10.1111/j.1365-2796.2011.02427.x, 21752111.